- Bevorzugter Name
- N,N-Bis(trimethylsilyl)-(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutylamine
- IUPAC
- (1R)-3-methyl-1-[(1S,2S,6R,8S)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.02,6]decan-4-yl]-N,N-bis(trimethylsilyl)butan-1-amine
- Englischer Name
- 4,6-Methano-1,3,2-benzodioxaborole-2-MethanaMine,hexahydro-3a,5,5-triMethyl-a-(2-Methylpropyl)-N,N-bis(triMethylsilyl)-,(aR,3aS,4S,6S,7aR)-
- Summenformel
- C21H44BNO2Si2
- Molmasse
- 409.57
Namen und Synonyme
514820-48-5Bortezomib Impurity 541,1,1-Trimethyl-N-((R)-3-methyl-1-((3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)-N-(trimethylsilyl)silanamineN,N-Bis(trimethylsilyl)-(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutylamine(1R)-3-Methyl-1-[(1S,2S,6R,8S)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.02,6]decan-4-yl]-N,N-bis(trimethylsilyl)butan-1-amineBortezomib Impurity N47SCHEMBL554519W6JS89955D1,1,1-Trimethyl-N-{(1r)-3-Methyl-1-[(3 as,4s,6s,7ar)-3a,5,5-Trimethylhexahydro-4,6-Methano-1,3,2-Benzodioxaborol-2-Y1]Butyl}-N-(Trimethylsilyl)Silanamine(alphaR,3aS,4S,6S,7aR)-Hexahydro-3a,5,5-trimethyl-alpha-(2-methylpropyl)-N,N-bis(trimethylsilyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine4,6-Methano-1,3,2-benzodioxaborole-2-methanamine, hexahydro-3a,5,5-trimethyl-alpha-(2-methylpropyl)-N,N-bis(trimethylsilyl)-, (alphaR,3aS,4S,6S,7aR)-Hexahydro-3a,5,5-trimethyl-alpha-(2-methylpropyl)-N,N-bis(trimethylsilyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine, (alphaR,3aS,4S,6S,7aR)-
Weitere Namen anzeigen
Bortezomib Impurity 764,6-Methano-1,3,2-benzodioxaborole-2-MethanaMine,hexahydro-3a,5,5-triMethyl-a-(2-Methylpropyl)-N,N-bis(triMethylsilyl)-,(aR,3aS,4S,6S,7aR)-4,6-Methano-1,3,2-benzodioxaborole-2-methanamine, hexahydro-3a,5,5-trimethyl-α-(2-methylpropyl)-N,N-bis(trimethylsilyl)-, (αR,3aS,4S,6S,7aR)-
